Biogen Pharmachem Industries Ltd - Stock Valuation and Financial Performance

BSE: 531752 | NSE: | Trading | Small Cap

Biogen Pharmachem Share Price

1.24 0.01 0.81%
as on 21-Nov'24 16:59

DeciZen - make an informed investing decision on Biogen Pharmachem

M-Cap below 100cr DeciZen not available

Biogen Pharmachem Industries stock performance -

mw4me loader
P/E Ratio (SA):
0.00
Market Cap:
80.3 Cr.
52-wk low:
0.8
52-wk high:
1.9

Is Biogen Pharmachem Industries Ltd an attractive stock to invest in?

1. Is Biogen Pharmachem Industries Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Biogen Pharmachem Industries Ltd is a below average quality company.

2. Is Biogen Pharmachem Industries Ltd undervalued or overvalued?

The key valuation ratios of Biogen Pharmachem Industries Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

3. Is Biogen Pharmachem Industries Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Biogen Pharmachem Industries Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Biogen Pharmachem:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Biogen Pharmachem Industries Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
ROCE % -0.1%-0%-0.2%-11.3%-0%-0.2%-2.9%-0%0.8%3.5%-
Value Creation
Index
-1.0-1.0-1.0-1.8-1.0-1.0-1.2-1.0-0.9-0.8-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 0000101.62.5000
Sales YoY Gr.-NANANANA-100%NA52.5%-100%NA-
Adj EPS 000-000-0000-0
YoY Gr.-NANANANANANANANANA-
BVPS (₹) 0.90.90.90.80.80.90.80.80.80.90.9
Adj Net
Profit
-0.10-0.1-1.90-0.1-0.50.200.8-1
Cash Flow from Ops. -7.34.7-0.1-13.70.1-1.241.41.71.9-
Debt/CF from Ops. -1.41.3-10.807.2-0.30000-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NA-100%-100%NA
Adj EPS NANANANA
BVPS-0.7%1%1.6%3.6%
Share Price 15.3% 38.9% 25.3% 59%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
Return on
Equity %
-0.2-0.1-0.2-3.3-0-0.2-0.90.4-01.5-1.2
Op. Profit
Mgn %
0000-0.400.31200NAN
Net Profit
Mgn %
0000-0.40-29.48.500-INF
Debt to
Equity
0.20.1000000000
Working Cap
Days
000019,937010,6176,835000
Cash Conv.
Cycle
00002,68301,181182000

Recent Performance Summary

No data to display

Return on Equity is Poor

Sales growth has been subdued in last 3 years -100.00%

Sales growth is not so good in last 4 quarters at 0.00%

Latest Financials - Biogen Pharmachem Industries Ltd.

Standalone Consolidated
TTM EPS (₹) -0 -
TTM Sales (₹ Cr.) 0 -
BVPS (₹.) 0.9 -
Reserves (₹ Cr.) -10 -
P/BV 1.45 -
PE 0.00 -
From the Market
52 Week Low / High (₹) 0.77 / 1.85
All Time Low / High (₹) 0.02 / 18.70
Market Cap (₹ Cr.) 80.3
Equity (₹ Cr.) 65.3
Face Value (₹) 1
Industry PE 69

Management X-Ray of Biogen Pharmachem:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Biogen Pharmachem

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Sales00000.9501.622.4700
Operating Expenses 0.140.030.126.720.950.123.232.490.460.45
Manufacturing Costs0000000000
Material Costs00000.9101.482.0100
Employee Cost 000.010.030.040.040.010.050.170.08
Other Costs 0.130.030.116.690.010.081.730.420.280.37
Operating Profit -0.14-0.03-0.12-6.720-0.12-1.60-0.02-0.46-0.45
Operating Profit Margin (%) -----0.4%--98.8%-0.6%--
Other Income 0000.150000.010.912.38
Interest 0000000000
Depreciation 0000000000
Exceptional Items 0000000000
Profit Before Tax -0.13-0.03-0.12-6.560-0.12-1.60-0.010.461.93
Tax 0000000000
Profit After Tax -0.13-0.03-0.12-6.560-0.12-1.60-0.010.461.93
PAT Margin (%) -----0.4%--98.8%-0.3%--
Adjusted EPS (₹)0.00.00.0-0.10.00.00.00.00.00.0
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24

Equity and Liabilities

Shareholders Fund 60.9960.9660.8454.2854.2755.7554.1454.1354.5956.52
Share Capital 65.2665.2665.2665.2665.2665.2665.2665.2665.2665.26
Reserves -4.27-4.30-4.42-10.98-10.99-9.51-11.12-11.13-10.67-8.74
Minority Interest0000000000
Debt106.210.720.010.630.310000
Long Term Debt7.666.210.720.010.630.310000
Short Term Debt2.34000000000
Trade Payables0.860001.0900.06000
Others Liabilities 1.641.641.691.641.640.040.050.820.240.30
Total Liabilities 73.4968.8163.2555.9357.6356.0954.2554.9554.8356.82

Fixed Assets

Gross Block0000000000
Accumulated Depreciation0000000000
Net Fixed Assets0000000000
CWIP 0000000000
Investments 43.7826.6922.393.526.256.459.496.958.855.44
Inventories0000000000
Trade Receivables0.86007.038.038.032.54000
Cash Equivalents 0.100.130.060.02000.010.080.130.02
Others Assets28.7541.9840.7945.3643.3541.6242.2147.9145.8551.36
Total Assets 73.4968.8163.2555.9357.6356.0954.2554.9554.8356.82

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Cash Flow From Operating Activity -7.284.68-0.07-13.650.09-1.213.951.401.701.94
PBT -0.13-0.03-0.12-6.560-0.12-1.60-0.010.461.93
Adjustment 0000000000
Changes in Working Capital -7.144.710.05-7.080.09-1.15.551.411.250.01
Tax Paid 0000000000
Cash Flow From Investing Activity 17.0817.084.3014.32-0.721.54-3.64-1.32-1.66-2.06
Capex 0000000000
Net Investments 17.0817.084.3018.88-2.73-0.20-3.042.54-1.903.41
Others 000-4.562.011.74-0.60-3.860.24-5.47
Cash Flow From Financing Activity -11.19-21.74-4.31-0.710.62-0.32-0.31000
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing 6.94-1.451.180000000
Interest Paid 0000000000
Dividend Paid 0000000000
Others -18.13-20.29-5.49-0.710.62-0.32-0.31000
Net Cash Flow -1.380.02-0.07-0.03-0.02000.080.05-0.11
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Ratios
ROE (%)-0.22-0.05-0.2-11.4-0.01-0.21-2.92-0.020.843.48
ROCE (%)-0.14-0.04-0.19-11.33-0.01-0.21-2.91-0.020.843.48
Asset Turnover Ratio00000.0200.030.0500
PAT to CFO Conversion(x)N/AN/AN/AN/AN/AN/AN/AN/A3.71.01
Working Capital Days
Receivable Days00002,89301,188000
Inventory Days0000000000
Payable Days0000219015000

Biogen Pharmachem Industries Ltd Stock News

Biogen Pharmachem Industries Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Biogen Pharmachem on 21-Nov-2024 16:59 is ₹1.24.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 21-Nov-2024 16:59 the market cap of Biogen Pharmachem stood at ₹80.27.
The latest P/E ratio of Biogen Pharmachem as of 21-Nov-2024 16:59 is 0.00.
The latest P/B ratio of Biogen Pharmachem as of 21-Nov-2024 16:59 is 1.45.
The 52-week high of Biogen Pharmachem is ₹1.85 and the 52-week low is ₹0.77.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Biogen Pharmachem is ₹0.00 ( Cr.) .

About Biogen Pharmachem Industries Ltd

Sun Techno Overseas Ltd., formerly Wellworth Overseas Limited, is an India-based company.In 2011 the company changed its name from Wellworth Overseas Ltd. to Sun Techno Overseas Ltd.

The company is engaged in the business of trading in shares and securities, small level of stock broking and consulting works. As of March 31, 2009, the company had started trading operations and business in commodities, both in agro-based and precious metals, and other goods in present and future markets.

The company is also diversifying its business activities in the power sector, by establishing wind power generation plant.

Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.